Regulation of Immunity by Butyrophilins

Annual Review of Immunology

Volumn 34, Issue , 2016, Pages 151-172

  Rhodes, David A ^a   Reith, Walter ^b   Trowsdale, John ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

B30.2; BTN1A; BTN2A; BTN3A; PRYSPRY

Indexed keywords

BUTYROPHILIN; CD3 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PERIPLAKIN; PLAKIN; PROTEIN; PROTEIN KINASE ZAP 70; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG; B7 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CHROMOSOME 17; GAMMA DELTA T LYMPHOCYTE; GENE CLUSTER; GENE LOCUS; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENETICS; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; T LYMPHOCYTE ACTIVATION; ANIMAL; BOVINE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MILK; MOUSE; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGEN-PRESENTING CELLS; B7 ANTIGENS; BUTYROPHILINS; CATTLE; HUMANS; IMMUNITY, INNATE; LYMPHOCYTE ACTIVATION; MICE; MILK; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84969792498     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-041015-055435     Document Type: Article

References (135)

1. Sharma P, Allison JP. 2015. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell 161:205-14
2. Quezada SA, Peggs KS, Simpson TR,Allison JP. 2011. Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication. Immunol. Rev. 241:104-18
3. Podojil JR, Miller SD. 2013. Targeting the B7 family of co-stimulatory molecules: successes and challenges. BioDrugs 27:1-13
4. Sharma P, Allison JP. 2015. The future of immune checkpoint therapy. Science 348:56-61
5. Arnett HA, Escobar SS, Viney JL. 2009. Regulation of costimulation in the era of butyrophilins. Cytokine 46:370-75
6. Abeler-Dorner L, Swamy M, Williams G, Hayday AC, Bas A. 2012. Butyrophilins: an emerging family of immune regulators. Trends Immunol. 33:34-41
7. Afrache H, Gouret P, Ainouche S, Pontarotti P, Olive D. 2012. The butyrophilin (BTN) gene family: from milk fat to the regulation of the immune response. Immunogenetics 64:781-94
8. Arnett HA, Viney JL. 2014. Immune modulation by butyrophilins. Nat. Rev. Immunol. 14:559-69
9. Henry J, Miller MM, Pontarotti P. 1999. Structure and evolution of the extended B7 family. Immunol. Today 20:285-88
10. Rhodes DA, Stammers M, Malcherek G, Beck S, Trowsdale J. 2001. The cluster of BTN genes in the extended major histocompatibility complex. Genomics 71:351-62
11. Compte E, Pontarotti P, Collette Y, Lopez M, Olive D. 2004. Frontline: characterization of BT3 molecules belonging to the B7 family expressed on immune cells. Eur. J. Immunol. 34:2089-99
12. Arnett HA, Escobar SS, Gonzalez-Suarez E, Budelsky AL, Steffen LA, et al. 2007. BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation. J. Immunol. 178:1523-33
13. Smith IA, Knezevic BR, Ammann JU, Rhodes DA, Aw D, et al. 2010. BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation. J. Immunol. 184:3514-25
14. Swanson RM, GavinMA, Escobar SS, Rottman JB, Lipsky BP, et al. 2013. Butyrophilin-like 2 modulates B7 costimulation to induce Foxp3 expression and regulatory T cell development in mature T cells. J. Immunol. 190:2027-35
15. Vantourout P, Hayday A. 2013. Six-of-The-best: unique contributions of γδT cells to immunology. Nat. Rev. Immunol. 13:88-100
16. Bonneville M, O'Brien RL, Born WK. 2010. γδTcell effector functions: a blend of innate programming and acquired plasticity. Nat. Rev. Immunol. 10:467-78
17. Hayday AC. 2009. γδT cells and the lymphoid stress-surveillance response. Immunity 31:184-96
18. Chien YH, Meyer C, Bonneville M. 2014. γδ T cells: first line of defense and beyond. Annu. Rev. Immunol. 32:121-55
19. Pennington DJ, Silva-Santos B, Hayday AC. 2005. γδT cell development-having the strength to get there. Curr. Opin. Immunol. 17:108-15
20. Ribot JC, Debarros A, Silva-Santos B. 2011. Searching for "signal 2": costimulation requirements of γδ T cells. Cell Mol. Life Sci. 68:2345-55
21. Ribot JC, Debarros A, Mancio-Silva L, Pamplona A, Silva-Santos B. 2012. B7-CD28 costimulatory signals control the survival and proliferation of murine and human γδ T cells via IL-2 production. J. Immunol. 189:1202-8
22. Boyden LM, Lewis JM, Barbee SD, Bas A, Girardi M, et al. 2008. Skint1, the prototype of a newly identified immunoglobulin superfamily gene cluster, positively selects epidermal γδT cells. Nat. Genet. 40:656-62
23. Harly C, Guillaume Y, Nedellec S, Peigne CM, Monkkonen H, et al. 2012. Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset. Blood 120:2269-79
24. Ruddy DA, Kronmal GS, Lee VK, Mintier GA, Quintana L, et al. 1997. A 1.1-Mb transcript map of the hereditary hemochromatosis locus. Genome Res. 7:441-56
25. Tazi-Ahnini R, Henry J, Offer C, Bouissou-Bouchouata C, Mather IH, Pontarotti P. 1997. Cloning, localization, and structure of new members of the butyrophilin gene family in the juxta-telomeric region of the major histocompatibility complex. Immunogenetics 47:55-63
26. Henry J, Ribouchon M, Depetris D, Mattei M, Offer C, et al. 1997. Cloning, structural analysis, and mapping of the B30 and B7 multigenic families to the major histocompatibility complex (MHC) and other chromosomal regions. Immunogenetics 46:383-95
27. Viken MK, Blomhoff A, Olsson M, Akselsen HE, Pociot F, et al. 2009. Reproducible association with type 1 diabetes in the extended class I region of the major histocompatibility complex. Genes Immun. 10:323-33
28. Valentonyte R, Hampe J, Huse K, Rosenstiel P, Albrecht M, et al. 2005. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat. Genet. 37:357-64
29. Pathan S, GowdyRE, Cooney R, Beckly JB,Hancock L, et al. 2009. Confirmation of the novel association at the BTNL2 locus with ulcerative colitis. Tissue Antigens 74:322-29
30. Prescott NJ, Lehne B, Stone K, Lee JC, Taylor K, et al. 2015. Pooled sequencing of 531 genes in inflammatory bowel disease identifies an associated rare variant in BTNL2 and implicates other immune related genes. PLOS Genet. 11:e1004955
31. Orozco G, Eerligh P, Sanchez E, Zhernakova S, Roep BO, et al. 2005. Analysis of a functional BTNL2 polymorphism in type 1 diabetes, rheumatoid arthritis, and systemic lupus erythematosus. Hum. Immunol. 66:1235-41
32. Traherne JA, Barcellos LF, Sawcer SJ,Compston A,Ramsay PP, et al. 2006. Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1 and z ast 15. Hum. Mol. Genet. 15:155-61
33. Schwartz JC, Zhang X, Fedorov AA, Nathenson SG, Almo SC. 2001. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature 410:604-8
34. Stamper CC, Zhang Y,Tobin JF, Erbe DV, Ikemizu S, et al. 2001. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature 410:608-11
35. Rhodes DA, de Bono B, Trowsdale J. 2005. Relationship between SPRY and B30.2 protein domains. Evolution of a component of immune defence? Immunology 116:411-17
36. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. 2004. The cytoplasmic body component TRIM5αrestricts HIV-1 infection in Old World monkeys. Nature 427:848-53
37. James LC, Keeble AH,Khan Z, Rhodes DA, Trowsdale J. 2007. Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function. PNAS 104:6200-5
38. Xu H, Yang J, GaoW, Li L, Li P, et al. 2014. Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature 513:237-41
39. de ZoeteMR, Flavell RA. 2014. Detecting "different": Pyrin senses modifiedGTPases. Cell Res. 24:1286-87
40. Caruso R, Warner N, Inohara N, Nunez G. 2014. NOD1 and NOD2: signaling, host defense, and inflammatory disease. Immunity 41:898-908
41. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, et al. 2001. The tripartite motif family identifies cell compartments. EMBO J. 20:2140-51
42. Nisole S, Stoye JP, Saib A. 2005. TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 3:799-808
43. Ozato K, Shin DM, Chang TH, Morse HC. 2008. TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. Immunol. 8:849-60
44. Rhodes DA, Trowsdale J. 2007. TRIM21 is a trimeric protein that binds IgG Fc via the B30.2 domain. Mol. Immunol. 44:2406-14
45. McEwan WA,Mallery DL, Rhodes DA, Trowsdale J, James LC. 2011. Intracellular antibody-mediated immunity and the role of TRIM21. BioEssays 33:803-9
46. McEwan WA, Tam JC, Watkinson RE, Bidgood SR, Mallery DL, James LC. 2013. Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21. Nat. Immunol. 14:327-36
47. Uchil PD, Hinz A, Siegel S, Coenen-Stass A, Pertel T, et al. 2013. TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity. J. Virol. 87:257-72
48. Pertel T, Hausmann S, Morger D, Zuger S, Guerra J, et al. 2011. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472:361-65
49. Nguyen T, Liu XK, Zhang Y, Dong C. 2006. BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation. J. Immunol. 176:7354-60
50. Ammann JU, Cooke A, Trowsdale J. 2013. Butyrophilin Btn2a2 inhibits TCR activation and phosphatidylinositol 3-kinase/Akt pathway signaling and induces Foxp3 expression in T lymphocytes. J. Immunol. 190:5030-6
51. Sarter K, Leimgruber E, Gobet F, Agrawal V, Dunand-Sauthier I, et al. 2016. Btn2a2, a T-cell immunomodulatory molecule coregulated with MHC class II genes. J. Exp. Med. 213:177-87
52. Malcherek G, Mayr L, Roda-Navarro P, Rhodes D, Miller N, Trowsdale J. 2007. The B7 homolog butyrophilin BTN2A1 is a novel ligand for DC-SIGN. J. Immunol. 179:3804-11
53. ReithW, LeibundGut-Landmann S,Waldburger JM. 2005. Regulation ofMHCclass II gene expression by the class II transactivator. Nat. Rev. Immunol. 5:793-806
54. Cubillos-Ruiz JR,MartinezD, Scarlett UK,Rutkowski MR,Nesbeth YC, et al. 2010. CD277 is a negative co-stimulatory molecule universally expressed by ovarian cancer microenvironmental cells. Oncotarget 1:329-38
55. Le Page C, Marineau A, Bonza PK, Rahimi K, Cyr L, et al. 2012. BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis. PLOS ONE 7:e38541
56. Bas A, Swamy M, Abeler-Dorner L,WilliamsG, Pang DJ, et al. 2011. Butyrophilin-like 1 encodes an enterocyte protein that selectively regulates functional interactions with T lymphocytes. PNAS 108:4376-81
57. Yamazaki T, Goya I, Graf D, Craig S, Martin-Orozco N, Dong C. 2010. A butyrophilin family member critically inhibits T cell activation. J. Immunol. 185:5907-14
58. Chapoval AI, Smithson G, Brunick L, Mesri M, Boldog FL, et al. 2013. BTNL8, a butyrophilin-like molecule that costimulates the primary immune response. Mol. Immunol. 56:819-28
59. Lewis JM, GirardiM, Roberts SJ, Barbee SD,Hayday AC, Tigelaar RE. 2006. Selection of the cutaneous intraepithelial γδ+ T cell repertoire by a thymic stromal determinant. Nat. Immunol. 7:843-50
60. Barbee SD, Woodward MJ, Turchinovich G, Mention JJ, Lewis JM, et al. 2011. Skint-1 is a highly specific, unique selecting component for epidermal T cells. PNAS 108:3330-35
61. Turchinovich G, Hayday AC. 2011. Skint-1 identifies a common molecular mechanism for the development of interferon-γ-secreting versus interleukin-17-secreting γδT cells. Immunity 35:59-68
62. Bonneville M. 2006. Selection of intraepithelial γδcells: the Holy GrIEL at last? Nat. Immunol. 7:791-92
63. Tanaka Y, Sano S, Nieves E, De Libero G, Rosa D, et al. 1994. Nonpeptide ligands for human γδ T cells. PNAS 91:8175-79
64. Sandstrom A, Peigne CM, Leger A, Crooks JE, Konczak F, et al. 2014. The intracellular B30.2 domain of butyrophilin 3a1 binds phosphoantigens to mediate activation of human Vγ9Vδ2 T cells. Immunity 40:490-500
65. Hsiao CH, Lin X, Barney RJ, Shippy RR, Li J, et al. 2014. Synthesis of a phosphoantigen prodrug that potently activates Vγ9Vδ2 T-lymphocytes. Chem. Biol. 21:945-54
66. Rhodes DA, Chen HC, Price AJ, Keeble AH, Davey MS, et al. 2015. Activation of human γδT cells by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin. J. Immunol. 194:2390-98
67. Vavassori S, Kumar A, Wan GS, Ramanjaneyulu GS, Cavallari M, et al. 2013. Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδT cells. Nat. Immunol. 14:908-16
68. Gober HJ, Kistowska M, Angman L, Jeno P, Mori L, De Libero G. 2003. Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells. J. Exp. Med. 197:163-68
69. Poggi A, Boero S, Musso A, Zocchi MR. 2013. Selective role of mevalonate pathway in regulating perforin but not FasL and TNFαrelease in human natural killer cells. PLOS ONE 8:e62932
70. EberlM, Hintz M, Reichenberg A, Kollas AK,Wiesner J, Jomaa H. 2003. Microbial isoprenoid biosynthesis and human γδT cell activation. FEBS Lett. 544:4-10
71. Kistowska M, Rossy E, Sansano S, Gober HJ, Landmann R, et al. 2008. Dysregulation of the host mevalonate pathway during early bacterial infection activates human TCR γδ cells. Eur. J. Immunol. 38:2200-9
72. BlancM,Hsieh WY,RobertsonKA, Watterson S, ShuiG, et al. 2011. Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis. PLOS Biol. 9:e1000598
73. Wang X, Hinson ER, Cresswell P. 2007. The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2:96-105
74. Seo JY, Yaneva R, Cresswell P. 2011. Viperin: a multifunctional, interferon-inducible protein that regulates virus replication. Cell Host Microbe 10:534-39
75. Freed-PastorWA, Mizuno H, Zhao X, Langerod A,MoonSH, et al. 2012. Mutant p53 disruptsmammary tissue architecture via the mevalonate pathway. Cell 148:244-58
76. Weekes MP, Tomasec P, Huttlin EL, Fielding CA, Nusinow D, et al. 2014. Quantitative temporal viromics: an approach to investigate host-pathogen interaction. Cell 157:1460-72
77. Fielding CA, Aicheler R, Stanton RJ, Wang EC, Han S, et al. 2014. Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation. PLOS Pathog. 10:e1004058
78. Hsu JL, van Boomen DJ, Tomasec P, Weekes MP, Antrobus R, et al. 2015. Plasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation byHCMV US2 in cooperation with UL141. PLOS Pathog. 11:e1004811
79. De Libero G, Lau SY, Mori L. 2014. Phosphoantigen presentation to TCR γδ cells, a conundrum getting less gray zones. Front. Immunol. 5:679
80. Harly C, Peigne CM, Scotet E. 2014. Molecules and mechanisms implicated in the peculiar antigenic activation process of human Vγ9Vδ2 T cells. Front. Immunol. 5:657
81. Karunakaran MM, Herrmann T. 2014. The Vγ9Vδ2 T cell antigen receptor and butyrophilin-3 A1: models of interaction, the possibility of co-evolution, and the case of dendritic epidermal T cells. Front. Immunol. 5:648
82. Gu S, NawrockaW, Adams EJ. 2014. Sensing of pyrophosphate metabolites by Vγ9V and delta 2 T cells. Front. Immunol. 5:688
83. Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J,Meehan B, et al. 2012. MR1 presentsmicrobial vitamin B metabolites to MAIT cells. Nature 491:717-23
84. Le Bourhis L, Dusseaux M, Bohineust A, Bessoles S, Martin E, et al. 2013. MAIT cells detect and efficiently lyse bacterially-infected epithelial cells. PLOS Pathog. 9:e1003681
85. Gold MC, Lewinsohn DM. 2013. Co-dependents: MR1-restricted MAIT cells and their antimicrobial function. Nat. Rev. Microbiol. 11:14-19
86. Borg NA,Wun KS,Kjer-NielsenL,WilceMC,Pellicci DG, et al. 2007. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 448:44-49
87. Wang H, Henry O, Distefano MD, Wang YC, Raikkonen J, et al. 2013. Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ9Vδ2 T cells. J. Immunol. 191:1029-42
88. Leung CL, Green KJ, Liem RK. 2002. Plakins: a family of versatile cytolinker proteins. Trends Cell Biol. 12:37-45
89. Jefferson JJ, Leung CL, Liem RK. 2004. Plakins: Goliaths that link cell junctions and the cytoskeleton. Nat. Rev. Mol. Cell Biol. 5:542-53
90. Bouameur JE, Favre B, Borradori L. 2014. Plakins, a versatile family of cytolinkers: roles in skin integrity and in human diseases. J. Investig. Dermatol. 134:885-94
91. Karashima T, Watt FM. 2002. Interaction of periplakin and envoplakin with intermediate filaments. J. Cell Sci. 115:5027-37
92. Boczonadi V, McInroy L, Maatta A. 2007. Cytolinker cross-talk: Periplakin N-terminus interacts with plectin to regulate keratin organisation and epithelial migration. Exp. Cell Res. 313:3579-91
93. Groot KR, Sevilla LM,Nishi K, DiColandrea T, Watt FM. 2004. Kazrin, a novel periplakin-interacting protein associated with desmosomes and the keratinocyte plasma membrane. J. Cell Biol. 166:653-59
94. Kalinin AE, Aho M, Uitto J, Aho S. 2005. Breaking the connection: caspase 6 disconnects intermediate filament-binding domain of periplakin from its actin-binding N-terminal region. J. Investig. Dermatol. 124:46-55
95. Beekman JM, Bakema JE, van Winkel JG, Leusen JH. 2004. Direct interaction between FcγRI (CD64) and periplakin controls receptor endocytosis and ligand binding capacity. PNAS 101:10392-97
96. van Heuvel AP, Vries-Smits AM, Weeren PC,Dijkers PF, Bruyn KM, et al. 2002. Binding of protein kinase B to the plakin family member periplakin. J. Cell Sci. 115:3957-66
97. DiColandrea T, Karashima T, Maatta A, Watt FM. 2000. Subcellular distribution of envoplakin and periplakin: insights into their role as precursors of the epidermal cornified envelope. J. Cell Biol. 151:573-86
98. Sevilla LM, Nachat R, Groot KR, Klement JF, Uitto J, et al. 2007. Mice deficient in involucrin, envoplakin, and periplakin have a defective epidermal barrier. J. Cell Biol. 179:1599-612
99. Cipolat S, HosteE,Natsuga K, Quist SR, WattFM.2014. Epidermal barrier defects link atopic dermatitis with altered skin cancer susceptibility. eLife 3:e01888
100. Ortega E, Buey RM, Sonnenberg A, de Pereda JM. 2011. The structure of the plakin domain of plectin reveals a non-canonical SH3 domain interacting with its fourth spectrin repeat. J. Biol. Chem. 286:12429-38
101. Miyashita Y,OzawaM. 2007. Increased internalization of p120-uncoupled E-cadherin and a requirement for a dileucine motif in the cytoplasmic domain for endocytosis of the protein. J. Biol. Chem. 282:11540-48
102. IshiyamaN, Lee SH, Liu S, Li GY, SmithMJ, et al. 2010. Dynamic and static interactions between p120 catenin and E-cadherin regulate the stability of cell-cell adhesion. Cell 141:117-28
103. Palakodeti A, Sandstrom A, Sundaresan L, Harly C, Nedellec S, et al. 2012. The molecular basis for modulation of humanVγ9Vδ2Tcell responses byCD277/butyrophilin-3 (BTN3A)-specific antibodies. J. Biol. Chem. 287:32780-90
104. Jeong J, Lisinski I, Kadegowda AK, Shin H, Wooding FB, et al. 2013. A test of current models for the mechanism of milk-lipid droplet secretion. Traffic 14:974-86
105. Ogg SL, Weldon AK, Dobbie L, Smith AJ, Mather IH. 2004. Expression of butyrophilin (Btn1a1) in lactatingmammary gland is essential for the regulated secretion ofmilk-lipid droplets. PNAS 101:10084-89
106. Decaup E, Duault C, Bezombes C, Poupot M, Savina A, et al. 2014. Phosphoantigens and butyrophilin 3A1 induce similar intracellular activation signaling in human TCRVγ9+ γδT lymphocytes. Immunol. Lett. 161:133-37
107. Yamashiro H, Yoshizaki S, Tadaki T, Egawa K, Seo N. 2010. Stimulation of human butyrophilin 3 molecules results in negative regulation of cellular immunity. J. Leukoc. Biol. 88:757-67
108. Simone R, Barbarat B, Rabellino A, Icardi G, Bagnasco M, et al. 2010. Ligation of the BT3 molecules, members of the B7 family, enhance the proinflammatory responses of human monocytes and monocytederived dendritic cells. Mol. Immunol. 48:109-18
109. Messal N, Mamessier E, Sylvain A, Celis-Gutierrez J, Thibult ML, et al. 2011. Differential role for CD277 as co-regulator of the immune signal in T and NK cells. Eur. J. Immunol. 41:3443-54
110. Jack LJ, Mather IH. 1990. Cloning and analysis of cDNA encoding bovine butyrophilin, an apical glycoprotein expressed in mammary tissue and secreted in association with the milk-fat globule membrane during lactation. J. Biol. Chem. 265:14481-86
111. Vorbach C, Harrison R, Capecchi MR. 2003. Xanthine oxidoreductase is central to the evolution and function of the innate immune system. Trends Immunol. 24:512-17
112. Jeong J, Rao AU, Xu J, Ogg SL, Hathout Y, et al. 2009. The PRY/SPRY/B30.2 domain of butyrophilin 1A1 (BTN1A1) binds to xanthine oxidoreductase: implications for the function of BTN1A1 in the mammary gland and other tissues. J. Biol. Chem. 284:22444-56
113. Sargeant TJ, Lloyd-Lewis B, Resemann HK, Ramos-Montoya A, Skepper J, Watson CJ. 2014. Stat3 controls cell death during mammary gland involution by regulating uptake of milk fat globules and lysosomal membrane permeabilization. Nat. Cell Biol. 16:1057-68
114. Gardinier MV, Amiguet P, Linington C, Matthieu JM. 1992. Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily. J. Neurosci. Res. 33:177-87
115. Pagany M, Jagodic M, Bourquin C, Olsson T, Linington C. 2003. Genetic variation in myelin oligodendrocyte glycoprotein expression and susceptibility to experimental autoimmune encephalomyelitis. J. Neuroimmunol. 139:1-8
116. Reindl M, Di Pauli F, Rostasy K, Berger T. 2013. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat. Rev. Neurol. 9:455-61
117. Guggenmos J, Schubart AS, Ogg S, Andersson M, Olsson T, et al. 2004. Antibody cross-reactivity between myelin oligodendrocyte glycoprotein and the milk protein butyrophilin in multiple sclerosis. J. Immunol. 172:661-68
118. Linington C, Berger T, Perry L, Weerth S, Hinze-Selch D, et al. 1993. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 23:1364-72
119. Delarasse C, Daubas P, Mars LT, Vizler C, Litzenburger T, et al. 2003. Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice. J. Clin. Investig. 112:544-53
120. Stefferl A, Schubart A, Storch M, Amini A, Mather I, et al. 2000. Butyrophilin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. J. Immunol. 165:2859-65
121. Bruno R, Sabater L, Sospedra M, Ferrer-Francesch X, Escudero D, et al. 2002. Multiple sclerosis candidate autoantigens except myelin oligodendrocyte glycoprotein are transcribed in human thymus. Eur. J. Immunol. 32:2737-47
122. Garcia-Vallejo JJ, Ilarregui JM, Kalay H, Chamorro S, Koning N, et al. 2014. CNS myelin induces regulatory functions of DC-SIGN-expressing, antigen-presenting cells via cognate interaction withMOG. J. Exp. Med. 211:1465-83
123. Ye TZ, Gordon CT, Lai YH, Fujiwara Y, Peters LL, et al. 2000. Ermap, a gene coding for a novel erythroid specific adhesion/receptor membrane protein. Gene 242:337-45
124. Su YY, Gordon CT, Ye TZ, Perkins AC, Chui DH. 2001. Human ERMAP: an erythroid adhesion/ receptor transmembrane protein. Blood Cells Mol. Dis. 27:938-49
125. Wagner FF, Poole J, FlegelWA. 2003. Scianna antigens including Rd are expressed by ERMAP. Blood 101:752-7
126. Kaufman J, Skjodt K, Salomonsen J. 1991. The B-G multigene family of the chicken major histocompatibility complex. Crit. Rev. Immunol. 11:113-43
127. Kaufman J, Salomonsen J. 1992. B-G: we know what it is, but what does it do? Immunol. Today 13:1-3
128. Salomonsen J, Chattaway JA, Chan AC, Parker A,Huguet S, et al. 2014. Sequence of a complete chicken BG haplotype shows dynamic expansion and contraction of two gene lineages with particular expression patterns. PLOS Genet. 10:e1004417
129. Salomonsen J, DunonD, Skjodt K, Thorpe D, Vainio O, Kaufman J. 1991. Chicken major histocompatibility complex-encoded B-G antigens are found on many cell types that are important for the immune system. PNAS 88:1359-63
130. Salomonsen J, Eriksson H, Skjodt K, Lundgreen T, Simonsen M, Kaufman J. 1991. The "adjuvant effect" of the polymorphic B-G antigens of the chicken major histocompatibility complex analyzed using purified molecules incorporated in liposomes. Eur. J. Immunol. 21:649-58
131. Goto RM, Wang Y, Taylor RL Jr, Wakenell PS, Hosomichi K, et al. 2009. BG1 has a major role in MHC-linked resistance to malignant lymphoma in the chicken. PNAS 106:16740-45
132. Elleder D, Stepanets V, Melder DC, Senigl F, Geryk J, et al. 2005. The receptor for the subgroup C avian sarcoma and leukosis viruses, Tvc, is related to mammalian butyrophilins, members of the immunoglobulin superfamily. J. Virol. 79:10408-19
133. Greenwald RJ, Freeman GJ, Sharpe AH. 2005. The B7 family revisited. Annu. Rev. Immunol. 23:515-48
134. Schwartz JC, Zhang X, Nathenson SG, Almo SC. 2002. Structural mechanisms of costimulation. Nat. Immunol. 3:427-34
135. Dong H, Zhu G, Tamada K, Chen L. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5:1365-69